亚太地区 MRD 检测市场：分析与预测（2023-2033）

亚太地区MRD（微量残存疾病）检测市场规模预计将从2023年的3亿美元增加至2033年的13.3亿美元，2023-2033年预测期间复合年增长率为16.06%。

MRD 检测市场正在扩大，原因有很多，包括扩大 MRD 检测的医疗保险覆盖范围及其在固体癌诊断中的应用。消费者意识的提高增加了对 MRD 检测的需求。医疗保健专业人员和研究人员正在认识到这一趋势，并将 MRD 检测融入临床实践，以满足患者的需求。

由于多种因素，亚太地区 MRD 检测市场正在经历显着成长。这包括扩大 MRD 检测的医疗保健覆盖范围以及 MRD 检测在固体癌诊断中的新作用。消费者对 MRD 检测的认识不断提高，导致全部区域对 MRD 检测的需求激增。医疗保健专业人员和研究人员已经认识到这一趋势，并积极致力于将 MRD 检测纳入常规临床程序，以有效满足患者需求。此外，亚太地区主要国家技术和医疗基础设施的进步进一步促进了 MRD 检测市场的扩大。亚太地区日益重视早期检测和精准医疗，这为 MRD 检测提供者和相关人员带来了巨大的机会。

本报告考察了亚太地区 MRD 检测市场，并提供了市场概述、最终用户、国家/地区的趋势以及参与市场的公司概况。

目录

执行摘要

第一章 市场

• 市场范围
• 调查方法
• 市场估算模型

第二章 市场概况

• MRD检查流程分析
• MRD 检测：固态肿瘤与骨髓恶性肿瘤
• MRD 检测的演变
• 市场足迹
• 市场规模及未来成长潜力

第三章业界考察

• MRD 检测的法律和法律规范
• 赎回场景
• 供应链分析
  • 用于实验室开发测试 (LDT)
  • 用于体外诊断 (IVD)

第四章 MRD 检测市场（按地区），2022-2033

• 概述
• 亚太地区
  • 亚太地区 MRD 检测市场（依最终用户）
  • 亚太地区 MRD 检测市场（按国家/地区）

第五章 公司简介

• Sysmex Corporation

The Asia-Pacific MRD Testing Market Expected to Reach $1.33 Billion by 2033

Introduction to Asia-Pacific MRD Testing Market

The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.

Market Introduction

The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.

Market Segmentation:

Segmentation 1: by End User

• Hospitals and Speciality Clinics
• Research Institutions
• Diagnostic Laboratories
• Other End Users

Segmentation 2: by Country

• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Growth/Marketing Strategy: The APAC MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.

Competitive Strategy: Key players in the APAC MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Markets

• 1.1 Market Scope
  • 1.1.1 Key Questions Answered in the Report
• 1.2 Research Methodology
  • 1.2.1 MRD Testing Market: Research Methodology
  • 1.2.2 Data Sources
• 1.3 Market Estimation Model
  • 1.3.1 Criteria for Company Profiling

2 Market Overview

• 2.1 MRD Testing Workflow Analysis
• 2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
• 2.3 Evolution of MRD Testing
• 2.4 Market Footprint
• 2.5 Market Size and Future Growth Potential

3 Industry Insights

• 3.1 Legal and Regulatory Framework of MRD Tests
  • 3.1.1 Asia-Pacific
• 3.2 Reimbursement Scenario
  • 3.2.1 Asia-Pacific
• 3.3 Supply Chain Analysis
  • 3.3.1 For Laboratory Developed Tests (LDTs)
  • 3.3.2 For In-Vitro Diagnostics (IVDs)

4 Minimal Residual Disease Testing Market (by Region), 2022-2033

• 4.1 Overview
• 4.2 Asia-Pacific
  • 4.2.1 Asia-Pacific MRD Testing Market, by End User
  • 4.2.2 Asia-Pacific MRD Testing Market, by Country

5 Company Profiles

• 5.1 Overview
• 5.2 Sysmex Corporation
  • 5.2.1 Company Overview
  • 5.2.2 Role of Sysmex Corporation in the MRD Testing Market
  • 5.2.3 Financials
  • 5.2.4 Analyst Perspective

List of Figures

• Figure 1: Asia-Pacific MRD Testing Market, $Billion, 2022 and 2033
• Figure 2: Share of Asia-Pacific MRD Testing Market (by End User), $Billion, 2022 and 2033
• Figure 3: Share of MRD Testing Market (by Region), 2022
• Figure 4: MRD Testing Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: MRD Testing Workflow
• Figure 9: Evolution of the MRD Testing Market
• Figure 10: Asia-Pacific MRD Testing Market Potential, $Billion, 2022-2033
• Figure 11: Supply Chain Analysis of Laboratory-Developed Tests
• Figure 12: Supply Chain Analysis of In-Vitro Diagnostics
• Figure 13: MRD Testing Market Snapshot (by Region)
• Figure 14: Asia-Pacific: Market Dynamics
• Figure 15: Asia-Pacific MRD Testing Market, $Billion, 2022-2033
• Figure 16: Asia-Pacific MRD Testing Market (by End User), $Million, 2022-2033
• Figure 17: Asia-Pacific MRD Testing Market (by Country), $Million, 2022-2033
• Figure 18: China MRD Testing Market, $Million, 2022-2033
• Figure 19: India MRD Testing Market, $Million, 2022-2033
• Figure 20: Japan MRD Testing Market, $Million, 2022-2033
• Figure 21: South Korea MRD Testing Market, $Million, 2022-2033
• Figure 22: Australia MRD Testing Market, $Million, 2022-2033
• Figure 23: Singapore MRD Testing Market, $Million, 2022-2033
• Figure 24: Rest-of-Asia-Pacific MRD Testing Market, $Million, 2022-2033
• Figure 25: MRD Testing Market, Total Number of Companies Profiled
• Figure 26: Sysmex Corporation: Product Portfolio
• Figure 27: Sysmex Corporation: Overall Financials, $Million, 2020-2022
• Figure 28: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 29: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
• Figure 30: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022

List of Tables

• Table 1: Impact Analysis of Market Drivers, Challenges, and Opportunities in the MRD Testing Market
• Table 2: Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
• Table 3: Registration Criteria for IVD Medical Devices as per CFDA